Amgen stockholders approve 31.3M share increase in equity plan, re-elect all 12 directors

AMGEN INC

Stockholders approved Second Amended and Restated 2009 Equity Incentive Plan, adding 31,297,000 shares.
All 12 director nominees elected; Dr. Mary E. Klotman appointed to committees effective June 1, 2024.
Advisory vote on executive compensation passed with 93.4% of votes cast in favor.
Ernst & Young ratified as independent auditor for fiscal year 2024 with 93.7% of votes cast.
Plan amendments include clarifying dividend-equity payout timing and change-of-control vesting rules.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.